Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.

Modifiable barriers for recruitment and retention of older adults participants from underrepresented minorities in alzheimer's disease research

Open access
Indorewalla, Khushnoo K., O’Connor, Maureen K., Budson, Andrew E., Guess (DiTerlizzi), Christina, Jackson, Jonathan · 2021 · Journal of Alzheimer’s Disease

Abstract

Clinical Alzheimer’s disease (AD) trials currently face a critical shortfall of thousands of eligible participants, which inflates the duration and cost of the clinical study as well as threatens the scientific merit of promising clinical interventions. This recruitment crisis is further compounded by the fact that underrepresented and marginalized populations—particularly those identifying as a racial or ethnic minority, those with low socioeconomic status, or living in rural areas—have been historically underrepresented in ongoing AD clinical trials despite overwhelming evidence that such populations are at increased risk for developing dementia. As a result of various recruitment barriers, current AD clinical studies frequently reflect a decreasingly representative segment of the US population, which threatens the overall generalizability of these findings. The current narrative review provides an updated examination and critique of common recruitment barriers and potential solutions, as well as a discussion of theoretical approaches that may address barriers disproportionately experienced by underrepresented communities. AD clinical researchers are encouraged to take purposive action aimed at increasing diversity of enrolled AD clinical trial cohorts by actively identifying and quantifying barriers to research participation—especially recruitment barriers and health disparities that disproportionately prevent underrepresented and marginalized populations from participating in research. Furthermore, researchers are encouraged to closely track which individuals who express interest in AD research ultimately enroll in research studies to examine whether AD research participation is appropriately representative of the intended population for whom these new and novel AD interventions are being designed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-201081

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 101 references

Research works printed but not linked: 8

  1. Institute of Medicine (US) (2012). The Clinical Trials Process, National Academies Press (US).
  2. Institute of Medicine (2010) Transforming Clinical Research in the United States: Challenges and Opportunities: Workshop Summary.
  3. Institute of Medicine (US) (2012) Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary, National Academies Press (US), Washington (DC).
  4. Evelyn B, 2001, J Natl Med Assoc, 93, 18S
  5. Seitz DP, 2018, Cochrane Database Syst Rev, 2, CD011415
  6. ManlyJ, MayeuxR (2004) Ethnic differences in dementia and Alzheimer’s disease. In Critical Perspectives on Racial and Ethnic Differences in Health in Late Life , Anderson NB, Bulatao RA, Cohen B, eds. The National Academies Press, pp. 95–142.
  7. Assistant Secretary for Planning and Evaluation (2014), Racial and Ethnic Disparities in Alzheimer’s Disease: A Literature Review.
  8. Boise L, 2017, Gerontologist, 57, 719

Cited by

See all 93

Metadata

Authors
Indorewalla, K. K., O’Connor, M. K., Budson, A. E., Guess (DiTerlizzi), C., & Jackson, J.
Affiliations
  • Edith Nourse Rogers Memorial Veterans Hospital (US)
  • Boston University (US)
  • Boston University Alzheimer’s Disease Research Center, Department of Neurology, Boston University School of Medicine, Boston, MA, USA
Corresponding author
Jackson, Jonathan
Venue
Journal of Alzheimer’s Disease
Published
2021-02-17
Volume
80
Issue
3
Pages
927-940
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W3130554957
Cited by
93
References
101
Citations by year
2026: 15 · 2025: 26 · 2024: 21 · 2023: 20 · 2022: 10 · 2021: 1
FWCI
2.32
Type
journal article
Language
en
Open access
Locations
  • Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Veterans Affairs (I01 CX001698)
  • National Institute on Aging (DP1AG069873, P30AG013846)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
participant recruitment
MeSH terms
Alzheimer Disease, Clinical Trials as Topic, Humans, Minority Groups, Patient Selection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modifiable barriers for recruitment and retention of older adults participants from underrepresented minorities in alzheimer's disease research. https://app.cochat.ai/papers/10.3233/jad-201081
The paper
Indorewalla, K. K., O’Connor, M. K., Budson, A. E., Guess (DiTerlizzi), C., & Jackson, J. (2021). Modifiable barriers for recruitment and retention of older adults participants from underrepresented minorities in alzheimer's disease research. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-201081

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.